A new strategy to design label-free electrochemical biosensor for ultrasensitive diagnosis of CYFRA 21-1 as a biomarker for detection of non-small cell lung cancer

被引:50
|
作者
Jafari-Kashi, Abbas [1 ]
Rafiee-Pour, Hossain-Ali [2 ]
Shabani-Nooshabadi, Mehdi [1 ,3 ]
机构
[1] Univ Kashan, Fac Chem, Dept Analyt Chem, Kashan, Iran
[2] Univ Kashan, Fac Chem, Dept Cell & Mol Biol, Kashan, Iran
[3] Univ Kashan, Inst Nano Sci & Nano Technol, Kashan, Iran
关键词
CYFRA21-1; Electrochemical biosensor; Lung cancer; Guanine oxidation; Label-free; COMPOSITE THIN-FILM; GRAPHENE OXIDE; DNA BIOSENSOR; NANOPARTICLES; FABRICATION; MARKER; ASSAY;
D O I
10.1016/j.chemosphere.2022.134636
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Lung cancer is one of the most dangerous cancers with high mortality rate among other cancers therefore, early detection of this cancer is very important. Many studies have been reported in ways of diagnostic lung cancer early. According to reports, one of the most important biomarkers to detect lung cancer is Cytokeratin 19 fragment 21-1 (CYFRA21-1), which is significantly related to non-small cell lung cancer, in particular, squamous cell carcinoma. Thus, finding a new method for the early diagnosis of CYFRA 21-1 (DNA target probe) is essential. In the present report, we design a novel label-free electrochemical DNA-biosensor related to the signal of guanine oxidation. The proposed DNA biosensor is fabricated by a modified glassy carbon electrode (GCE) with reduced-graphene oxide (rGO), poly pyrrole (PPy), silver nanoparticles (AgNPs) and single-strand DNA (ssDNA as capture probe) GCE/rGO/PPy/AgNPs/ssDNA. The differential pulse voltammetry (DPV) and cyclic voltammetry (CV) techniques are used to verify the hybridization process between capture and target probes. Electrochemical impedance spectroscopy (EIS), energy diffraction X-ray (EDX) and field-emission scanning microscopy (FE-SEM) techniques are applied to the characterization of different modified GCE surfaces as well as Xray diffraction (XRD) for graphene oxide synthesis. The XRD pattern of the synthesized GO that its diffraction peak appears at 10.2. The applied CV and DPV for the guanine oxidation are determined under optimal conditions. The label-free DNA biosensor showed a great result for the determination of CYFRA21-1 with a wide linear range from two consecutive linear relationships of peak current and CYFRA21-1 concentration were found(1.0 x 10(-14) -1.0 x 10(-10) M, R-2 = 0.9936 and 1.0 x 10(-9) -1.0 x 10(-6) M, R-2 = 0.9955). Proposed electrochemical biosensor displayed low detection limit (2.4 fM).
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer
    Nisman, B
    Amir, G
    Lafair, J
    Heching, N
    Lyass, O
    Peretz, T
    Barak, V
    ANTICANCER RESEARCH, 1999, 19 (4C) : 3549 - 3552
  • [32] CYFRA 21-1 as a Predictive Marker for Non-small Cell Lung Cancer Treated with Pemetrexed-based Chemotherapy
    Sone, Kazuki
    Oguri, Tetsuya
    Nakao, Makoto
    Kagawa, Yusuke
    Kurowaka, Ryota
    Furuta, Hiromi
    Fukuda, Satoshi
    Uemura, Takehiro
    Takakuwa, Osamu
    Kanemitsu, Yoshihiro
    Ohkubo, Hirotsugu
    Takemura, Masaya
    Maeno, Ken
    Ito, Yutaka
    Sato, Hidefumi
    Muramatsu, Hideki
    Niimi, Akio
    ANTICANCER RESEARCH, 2017, 37 (02) : 935 - 939
  • [33] Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer
    Barlési, F
    Gimenez, C
    Torre, JP
    Doddoli, C
    Mancini, J
    Greillier, L
    Roux, F
    Kleisbauer, JP
    RESPIRATORY MEDICINE, 2004, 98 (04) : 357 - 362
  • [34] Combination of serum miRNAs with Cyfra21-1 for the diagnosis of non-small cell lung cancer
    Zhou, Chengcheng
    Chen, Zhaoli
    Dong, Jingsi
    Li, Jiagen
    Shi, Xuejiao
    Sun, Nan
    Luo, Mei
    Zhou, Fang
    Tan, Fengwei
    He, Jie
    CANCER LETTERS, 2015, 367 (02) : 138 - 146
  • [35] CYFRA 21-1 in the early diagnosis of recurrent disease in non small cell lung carcinomas (NSCLC)
    Stieber, P
    Zimmermann, A
    Reinmiedl, J
    Müller, C
    Hoffmann, H
    Dienemann, H
    ANTICANCER RESEARCH, 1999, 19 (4A) : 2665 - 2668
  • [36] Electrochemical aptasensor design for label free cytosensing of human non-small cell lung cancer
    Kara, P.
    Erzurumlu, Y.
    Kirmizibayrak, P. Ballar
    Ozsoz, M.
    JOURNAL OF ELECTROANALYTICAL CHEMISTRY, 2016, 775 : 337 - 341
  • [37] The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: A meta-analysis
    Cui, Chao
    Sun, Xin
    Zhang, Jun
    Han, Dong
    Gu, Jundong
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (07) : C131 - C134
  • [38] Measurements and clinical evaluation of Cyfra 21-1 as a new tumour marker for non-small-cell lung cancer
    Chen, Q
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A60 - A60
  • [39] A Versatile Electrochemical Biosensor for the Detection of Circulating MicroRNA toward Non-Small Cell Lung Cancer Diagnosis
    Meng, Fanyu
    Yu, Wenjun
    Chen, Changqiang
    Guo, Susu
    Tian, Xiaoting
    Miao, Yayou
    Ma, Lifang
    Zhang, Xiao
    Yu, Yongchun
    Huang, Lin
    Qian, Kun
    Wang, Jiayi
    SMALL, 2022, 18 (22)
  • [40] Preoperative CYFRA 21-1 levels as a prognostic factor in c-stage I non-small cell lung cancer
    Suzuki, Hisashi
    Ishikawa, Shigemi
    Satoh, Hiroaki
    Ishikawa, Hiroichi
    Sakai, Mitsuaki
    Yamamoto, Tatsuo
    Onizuka, Masataka
    Sakakibara, Yuzuru
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2007, 32 (04) : 648 - 652